Enovis (ENOV) Cash & Current Investments (2010 - 2026)
Enovis (ENOV) posted quarterly Cash & Current Investments of $33.1 million for Q2 2026, down 13.86% year-over-year from $38.5 million in Q2 2025, and down 8.96% quarter-over-quarter from $36.4 million in Q4 2025.
Enovis (ENOV) Cash & Current Investments (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Cash & Current Investments for 17 consecutive years, with $33.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Current Investments fell 13.86% year-over-year to $33.1 million; the TTM figure through Apr 2026 stood at $33.1 million (down 13.86% YoY), while the FY2025 annual figure was $36.4 million, down 24.45% from the prior year.
- Cash & Current Investments declined to $33.1 million in Q2 2026 per ENOV's latest filing, from $36.4 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $661.5 million in Q2 2022 and bottomed at $21.9 million in Q1 2023.
- Historically, Cash & Current Investments has averaged $105.5 million across 5 years, with a median of $36.2 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Current Investments surged 475.64% — and 2023, when it tumbled 96.69%.
- Enovis' Cash & Current Investments stood at $24.3 million in 2022, then jumped by 48.96% to $36.2 million in 2023, then jumped by 33.09% to $48.2 million in 2024, then retreated by 24.45% to $36.4 million in 2025, then dropped by 8.96% to $33.1 million in 2026.
- Business Quant data shows ENOV's Cash & Current Investments at $33.1 million in Q2 2026, $36.4 million in Q4 2025, and $33.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn | 12.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 12.56 Mn |
| Apr 3, 2026 | 33.13 Mn |
| Dec 31, 2025 | 36.39 Mn |
| Oct 3, 2025 | 33.62 Mn |
| Jul 4, 2025 | 44.07 Mn |
| Apr 4, 2025 | 38.46 Mn |
| Dec 31, 2024 | 48.17 Mn |
| Sep 27, 2024 | 35.43 Mn |
| Jun 28, 2024 | 35.00 Mn |
| Mar 29, 2024 | 66.27 Mn |
| Dec 31, 2023 | 36.19 Mn |
| Sep 29, 2023 | 32.13 Mn |
| Jun 30, 2023 | 32.49 Mn |
| Mar 31, 2023 | 21.90 Mn |
| Dec 31, 2022 | 24.30 Mn |
| Sep 30, 2022 | 255.23 Mn |
| Jul 1, 2022 | 358.68 Mn |
| Apr 1, 2022 | 661.50 Mn |
| Dec 31, 2021 | 680.25 Mn |
| Oct 1, 2021 | 177.48 Mn |